Novel correlates of protection against pandemic H1N1 influenza A virus infection-Reference-Cited by-同舟云学术

Novel correlates of protection against pandemic H1N1 influenza A virus infection

Published:2019-06 Issue:6 Volume:25 Page:962-967
ISSN:1078-8956
Container-title:Nature Medicine
language:en
Short-container-title:Nat Med

Author:

Ng Sophia,Nachbagauer Raffael^ORCID,Balmaseda Angel,Stadlbauer Daniel^ORCID,Ojeda Sergio,Patel Mayuri,Rajabhathor Arvind^ORCID,Lopez Roger,Guglia Andrea F.,Sanchez Nery,Amanat Fatima,Gresh Lionel^ORCID,Kuan Guillermina,Krammer Florian^ORCID,Gordon Aubree^ORCID

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://www.nature.com/articles/s41591-019-0463-x.pdf

Reference42 articles.

1. Nair, H. et al. Global burden of respiratory infections due to seasonal influenza in young children: a systematic review and meta-analysis. Lancet 378, 1917–1930 (2011).

2. Thompson, W. W. et al. Estimates of US influenza-associated deaths made using four different methods. Influenza Other Respir. Viruses 3, 37–49 (2009).

3. Nachbagauer, R. & Krammer, F. Universal influenza virus vaccines and therapeutic antibodies. Clin. Microbiol. Infect. 23, 222–228 (2017).

4. Jacobsen, H. et al. Influenza virus hemagglutinin stalk-specific antibodies in human serum are a surrogate marker for in vivo protection in a serum transfer mouse challenge model. MBio 8, e01463-17 (2017).

5. Nachbagauer, R. et al. A universal influenza virus vaccine candidate confers protection against pandemic H1N1 infection in preclinical ferret studies. NPJ Vaccines 2, 26 (2017).

Cited by 151 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fc-dependent protective efficacy of non-inhibitory antibodies targeting influenza A virus neuraminidase is limited by epitope availability;2024-09-03

2. Influenza Vaccine Effectiveness and Progress Towards a Universal Influenza Vaccine;Drugs;2024-08-21

3. A Randomized, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of VIR-2482 in Healthy Adults for Prevention of Influenza A Illness (PENINSULA);Clinical Infectious Diseases;2024-07-22

4. Site‐specific serology unveils cross‐reactive monoclonal antibodies targeting influenza A hemagglutinin epitopes;European Journal of Immunology;2024-07-19

5. Anti-Neuraminidase Antibodies Reduce the Susceptibility to and Infectivity of Influenza A/H3N2 Virus;2024-06-15